vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and LIVE VENTURES Inc (LIVE). Click either name above to swap in a different company.

LIVE VENTURES Inc is the larger business by last-quarter revenue ($108.5M vs $77.6M, roughly 1.4× Bioceres Crop Solutions Corp.). LIVE VENTURES Inc runs the higher net margin — -0.1% vs -9.6%, a 9.5% gap on every dollar of revenue. On growth, LIVE VENTURES Inc posted the faster year-over-year revenue change (-2.7% vs -16.8%). Over the past eight quarters, LIVE VENTURES Inc's revenue compounded faster (-4.3% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Live Nation Entertainment, Inc. is an American multinational entertainment company that was founded in 2010 following the merger of Live Nation and Ticketmaster. It continues to operate both brands as subsidiary companies, promoting and managing ticket sales for live entertainment internationally. It also owns and operates entertainment venues and manages the careers of music artists.

BIOX vs LIVE — Head-to-Head

Bigger by revenue
LIVE
LIVE
1.4× larger
LIVE
$108.5M
$77.6M
BIOX
Growing faster (revenue YoY)
LIVE
LIVE
+14.2% gap
LIVE
-2.7%
-16.8%
BIOX
Higher net margin
LIVE
LIVE
9.5% more per $
LIVE
-0.1%
-9.6%
BIOX
Faster 2-yr revenue CAGR
LIVE
LIVE
Annualised
LIVE
-4.3%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BIOX
BIOX
LIVE
LIVE
Revenue
$77.6M
$108.5M
Net Profit
$-7.4M
$-64.0K
Gross Margin
46.8%
32.6%
Operating Margin
9.3%
3.2%
Net Margin
-9.6%
-0.1%
Revenue YoY
-16.8%
-2.7%
Net Profit YoY
-20.2%
-113.0%
EPS (diluted)
$-0.12
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
LIVE
LIVE
Q4 25
$108.5M
Q3 25
$77.6M
$113.9M
Q2 25
$112.5M
Q1 25
$60.6M
$107.0M
Q4 24
$98.8M
$111.5M
Q3 24
$93.3M
$112.7M
Q2 24
$123.9M
Q1 24
$84.0M
$118.6M
Net Profit
BIOX
BIOX
LIVE
LIVE
Q4 25
$-64.0K
Q3 25
$-7.4M
$997.0K
Q2 25
$5.4M
Q1 25
$-1.6M
$15.9M
Q4 24
$605.2K
$492.0K
Q3 24
$-6.2M
$-19.9M
Q2 24
$-2.9M
Q1 24
$9.8M
$-3.3M
Gross Margin
BIOX
BIOX
LIVE
LIVE
Q4 25
32.6%
Q3 25
46.8%
32.4%
Q2 25
34.0%
Q1 25
39.4%
32.8%
Q4 24
42.0%
31.7%
Q3 24
40.2%
31.9%
Q2 24
29.9%
Q1 24
50.8%
29.9%
Operating Margin
BIOX
BIOX
LIVE
LIVE
Q4 25
3.2%
Q3 25
9.3%
3.3%
Q2 25
7.1%
Q1 25
1.5%
2.0%
Q4 24
14.5%
0.7%
Q3 24
2.5%
-15.5%
Q2 24
0.9%
Q1 24
15.7%
-0.7%
Net Margin
BIOX
BIOX
LIVE
LIVE
Q4 25
-0.1%
Q3 25
-9.6%
0.9%
Q2 25
4.8%
Q1 25
-2.6%
14.8%
Q4 24
0.6%
0.4%
Q3 24
-6.6%
-17.6%
Q2 24
-2.3%
Q1 24
11.6%
-2.8%
EPS (diluted)
BIOX
BIOX
LIVE
LIVE
Q4 25
$-0.02
Q3 25
$-0.12
$-1.52
Q2 25
$1.24
Q1 25
$-0.02
$5.05
Q4 24
$0.00
$0.16
Q3 24
$-0.10
$-6.31
Q2 24
$-0.91
Q1 24
$0.14
$-1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
LIVE
LIVE
Cash + ST InvestmentsLiquidity on hand
$15.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$95.3M
Total Assets
$734.9M
$389.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
LIVE
LIVE
Q4 25
Q3 25
$15.5M
Q2 25
Q1 25
$38.5M
Q4 24
$29.2M
Q3 24
$32.3M
Q2 24
Q1 24
$16.4M
Stockholders' Equity
BIOX
BIOX
LIVE
LIVE
Q4 25
$95.3M
Q3 25
$288.3M
$95.3M
Q2 25
$94.3M
Q1 25
$345.0M
$88.9M
Q4 24
$346.3M
$73.3M
Q3 24
$346.0M
$72.9M
Q2 24
$92.7M
Q1 24
$348.5M
$95.9M
Total Assets
BIOX
BIOX
LIVE
LIVE
Q4 25
$389.2M
Q3 25
$734.9M
$386.4M
Q2 25
$387.5M
Q1 25
$798.2M
$393.6M
Q4 24
$835.2M
$395.5M
Q3 24
$827.3M
$407.5M
Q2 24
$436.8M
Q1 24
$836.1M
$433.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
LIVE
LIVE
Operating Cash FlowLast quarter
$14.4M
$9.8M
Free Cash FlowOCF − Capex
$8.5M
FCF MarginFCF / Revenue
7.8%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$21.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
LIVE
LIVE
Q4 25
$9.8M
Q3 25
$14.4M
$6.8M
Q2 25
$12.3M
Q1 25
$23.3M
$231.0K
Q4 24
$-5.4M
$9.4M
Q3 24
$5.2M
$6.7M
Q2 24
$11.7M
Q1 24
$-17.4M
$-5.7M
Free Cash Flow
BIOX
BIOX
LIVE
LIVE
Q4 25
$8.5M
Q3 25
$4.8M
Q2 25
$10.8M
Q1 25
$-2.3M
Q4 24
$7.6M
Q3 24
$3.3M
Q2 24
$10.1M
Q1 24
$-7.5M
FCF Margin
BIOX
BIOX
LIVE
LIVE
Q4 25
7.8%
Q3 25
4.2%
Q2 25
9.6%
Q1 25
-2.1%
Q4 24
6.8%
Q3 24
2.9%
Q2 24
8.2%
Q1 24
-6.3%
Capex Intensity
BIOX
BIOX
LIVE
LIVE
Q4 25
1.2%
Q3 25
1.7%
Q2 25
1.3%
Q1 25
2.3%
Q4 24
1.6%
Q3 24
3.1%
Q2 24
1.3%
Q1 24
1.4%
Cash Conversion
BIOX
BIOX
LIVE
LIVE
Q4 25
Q3 25
6.78×
Q2 25
2.28×
Q1 25
0.01×
Q4 24
-8.85×
19.11×
Q3 24
Q2 24
Q1 24
-1.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIOX
BIOX

Segment breakdown not available.

LIVE
LIVE

Steel Manufacturing Segment$31.9M29%
Flooring Manufacturing Segment$28.9M27%
Retail Flooring Segment$25.3M23%
Retail Entertainment Segment$23.6M22%

Related Comparisons